Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 6929 Results

OU’s Kopchick receives Ohio Patent Impact Award

Ohio University scientist John Kopchick will receive the Ohio Patent Impact Award for his contributions to the development of a drug that treats acromegaly, a growth hormone disorder related to gigantism that affects thousands of people worldwide. “I am awestruck by such a prestigious award. It is sincerely humbling,” said Kopchick, who is known as […]

April 4, 2012

Research Organics acquired by Sigma-Aldrich

Sigma-Aldrich Corporation announced today it has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics, Inc., to expand buffer production capacity and increase its portfolio of raw materials for the biopharmaceutical and diagnostic markets. Founded in 1953, Research Organics is a leading supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, […]

April 3, 2012

What’s a PDUFA?

BioOhio recently partnered with the Campaign for Modern Medicines (CMM) to urge Congress to get new, safe medicines to market faster by quickly reauthorizing PDUFA (Prescription Drug User Fee Act). So, What Is PDUFA? The Prescription Drug User Fee Act (PDUFA) was first passed by Congress in 1992 to allow the FDA to collect fees […]

March 30, 2012

Six Ohio children’s hospitals receive $2 million from state for collaborative research project

Following through on a comment he made during a tour of Nationwide Children’s Hospital last year, Ohio Governor John Kasich announced a $2 million award for six children’s hospitals across the state to collaborate on two research projects. Kasich spoke to the press in the Statehouse, flanked by leaders from Nationwide Children’s, Cincinnati Children’s, Akron Children’s, […]

March 28, 2012

An “OhioHealthy” environment for invention

Columbus’ NBC4 shines much-deserved light on OhioHealth Research and Innovation Institute’s efforts to “move inventions from head to hospital.”

March 28, 2012

Valley View company begins clinical study with University of Cincinnati

A few weeks after receiving additional patent coverage, Great Lakes NeuroTechnologies has launched a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The NIH-funded study is being conducted in partnership with Dr. Alberto Espay of the University of Cincinnati and Dr. Peter LeWitt […]

March 27, 2012

BIO praises Senate passage of the Jumpstart Our Business Startups (JOBS) Act

The Biotechnology Industry Organization (BIO) applauds the Senate on the passage of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act. Passing the Senate by a vote of 73-26, the Act contains several provisions which would make the pathway to capital formation more attainable for small biotechnology companies, clearing the way for American innovation and […]

March 23, 2012

Aerpio announces positive Phase 1 data

Cincinnati-based Aerpio Therapeutics this week announced positive data from its Phase 1 trial of a treatment for diabetic macular edema (DME). Aerpio’s AKB-9778, a first-in-class human protein tyrosine phosphatase beta (HPTPB) inhibitor, works to activate Tie2, a receptor on vascular endothelial cells that promotes vascular stability, preventing abnormal blood vessel growth and vascular leak. The […]

March 22, 2012

Cincinnati partnership will focus on aging-related startup technologies

CincyTech and Linkage Ventures have formed a unique strategic partnership to create and co-invest in startup companies whose technologies can help people as they age. Cincinnati-based CincyTech is a public-private seed-stage investor that has invested since 2007 in 35 startup companies in IT and bioscience. Linkage Ventures is a newly created venture arm of Linkage, […]

March 21, 2012